网站主页 >> CAS数据库列表 >> 4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride
4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride
|
|
- CAS号:
- 142715-48-8
- 英文名:
- 4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride
- 英文别名:
- CP-100356 Monohydrochloride;CP100356 hydrochloride,CP 100356 hydrochloride;4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride
- 中文名:
- 4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride
- 中文别名:
- 化合物 T22680;CP-100356盐酸盐;4-(6,7-二甲氧基-3,4-二氢异喹啉-2(1H)-基)-N-(3,4-二甲氧基苯乙基)-6,7-二甲氧基喹唑啉-2-胺盐酸盐
- CBNumber:
- CB52620898
- 分子式:
- C31H37ClN4O6
- 分子量:
- 597.10168
- MOL File:
- 142715-48-8.mol
|
|
|
4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride化学性质
-
储存条件:
-
2-8°C
-
|
-
溶解度:
-
DMSO: >5mg/mL
-
|
-
形态:
-
powder
-
|
-
颜色:
-
white to off-white
-
|
4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride性质、用途与生产工艺
CP-100356 hydrochloride 是一种具有口服活性的 MDR1/BCRP 双重抑制剂,可以抑制 MDR1 介导的 Calcein-AM 转运 (IC50=0.5 µM) 和 BCRP 介导的 Prazosin 转运 (IC50=1.5 µM)。CP-100356 hydrochloride 也是 OATP1B1 的弱抑制剂 (IC50=∼66 µM)。CP-100356 hydrochloride 对 MRP2 和主要的人 P450 酶没有抑制作用 (IC50>15 µM)。
IC50: 0.5 µM (MDR1), 1.5 µM (BCRP) in MDCKII cells
CP-100356 (0.1-15 µM; pretreated for 30 min) inhibits acetoxymethyl Calcein (Calcein-AM) uptake and and Digoxin transport in human MDR1-transfected MDCKII cells, with IC
50
s of 0.50 µM and 1.2 µM, respectively. CP-100356 decreases the BCRP-mediated transport of Prazosin in MDCKII cells, with an IC
50
of 1.5 µM.
CP-100356 (0.064-200 µM; 5 min) inhibits OATP1B1-mediated uptake of Estradiol 17β-D-Glucuronide, with an IC
50
of ~66 µM.
CP-100356 (0-50 µM; 10-30 min) is devoid of inhibition (IC
50
>50 µM) against the catalytic activity of the individual P450 enzymes including P4503A4 in the competitive inhibition study.
CP-100356 (6-24 mg/kg; p.o.) increases the systemic exposure of Fexofenadine (36- and 80-fold increase in C
max and AUC at the dose of 24 mg/kg) in rats.
4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride
上下游产品信息
上游原料
下游产品
4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride
生产厂家
142715-48-8, 4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride 相关搜索:
- Amine, Aromatics, Heterocycles, Pfizer Compounds, Pharmaceuticals, Intermediates & Fine Chemicals
- Pharmaceuticals
- Pfizer Compounds
- Intermediates & Fine Chemicals
- Heterocycles
- Aromatics
- Amine
- CP-100356盐酸盐
- 化合物 T22680
- 4-(6,7-二甲氧基-3,4-二氢异喹啉-2(1H)-基)-N-(3,4-二甲氧基苯乙基)-6,7-二甲氧基喹唑啉-2-胺盐酸盐
- 142715-48-8
- CP100356 hydrochloride,CP 100356 hydrochloride
- CP-100356 Monohydrochloride
- 4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride